The latest news and information from Costa Rica including breaking news, weather, travel, events, sports and more.

The US Food and Drug Administration (FDA) has approved Novo Nordisk's new once-daily pill for weight management, designed to help people reduce excess ...

FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.

Custom formulations of popular weight loss medications have surged in popularity due to the high costs of FDA-approved drugs.

Obesity can have a similar impact to cancer on a child's quality of life and should be considered a long-term chronic disease, doctors said at a conference assessing the effects of the latest ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...

Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U. in the first full week after its launch in an ...

LIR Life Sciences is a leader in the dvancement of novel, needle-free drug delivery platforms for obesity treatment across ...

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at 13 weeks for adults with overweight or obesity, according to findings from ...

In December, Novo Nordisk announced that the Food and Drug Administration had approved its once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. It remains the only ...

Thailand’s Public Health Ministry is ramping up efforts to combat the rising obesity rates and the broader issue of NCDs ...